Aug 6, 2026 04:05PM
Jul 28, 2026 07:30AM
May 6, 2026 12:49AM
Apr 20, 2026 04:05PM
Apr 16, 2026 10:42PM
Apr 16, 2026 10:42PM
Apr 16, 2026 04:08PM Trevi Therapeutics announces $150 million public stock offering
Apr 16, 2026 04:08PM
Dec 19, 2025 07:50AM
Nov 4, 2025 07:30AM
Aug 7, 2025 04:05PM
Jul 29, 2025 07:30AM
Jun 5, 2025 04:30PM
Jun 4, 2025 05:56AM Trevi Therapeutics (TRVI) Offering 17.4M Shares at $5.75
Jun 3, 2025 10:15PM
Jun 3, 2025 06:26AM
Jun 2, 2025 04:01PM
Jun 2, 2025 04:01PM
May 20, 2025 08:03AM
Apr 23, 2025 10:04AM
Mar 19, 2025 07:13AM Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI)
Mar 10, 2025 07:46AM
Feb 20, 2025 09:30AM
Dec 16, 2024 07:37AM
Dec 16, 2024 07:36AM
Nov 6, 2024 04:05PM
Oct 15, 2024 07:30AM
Aug 8, 2024 04:05PM Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance
Jul 2, 2024 07:30AM
Nov 9, 2023 04:05PM
Aug 10, 2023 04:05PM
Aug 1, 2023 07:30AM
Nov 10, 2022 04:05PM
Nov 8, 2022 07:30AM
Sep 23, 2022 05:52AM Trevi Therapeutics (TRVI) Prices $50M Offering
Sep 22, 2022 11:26PM
Sep 22, 2022 04:01PM
Sep 22, 2022 04:01PM
Aug 11, 2022 04:05PM
Apr 7, 2022 08:06AM
Apr 7, 2022 08:00AM
Nov 10, 2021 04:05PM Trevi Therapeutics Announces Third Quarter 2021 Financial Results and Business Update
Nov 9, 2021 07:30AM
Sep 30, 2021 06:57PM
Nov 10, 2020 07:30AM
Nov 10, 2020 07:30AM
Jul 13, 2020 11:42AM
Nov 13, 2019 05:01PM
Nov 13, 2019 05:01PM Trevi Therapeutics to Present at Stifel Healthcare Conference
Jun 3, 2019 07:16AM

43,588 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All